Literature DB >> 21038469

Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice.

Dorit Becher1, Michael E Deutscher, Kim R Simpfendorfer, Odilia L Wijburg, John S Pederson, Andrew M Lew, Richard A Strugnell, Anna K Walduck.   

Abstract

Helicobacter pylori is recognised as the chief cause of chronic gastritis, ulcers and gastric cancer in humans. With increased incidence of treatment failure and antibiotic resistance, development of prophylactic or therapeutic vaccination is a desirable alternative. Although the results of vaccination studies in animal models have been promising, studies in human volunteers have revealed problems such as 'post-immunisation gastritis' and comparatively poor responses to vaccine antigens. The focus of this study was to compare the gastric and systemic cellular immune responses induced by recombinant attenuated Salmonella Typhimurium-based vaccination in the C57BL/6 model of H. pylori infection. Analysis of lymphocyte populations in the gastric mucosa, blood, spleen, paragastric LN and MLN revealed that the effects of vaccination were largely confined to the parenchymal stomach rather than lymphoid organs. Vaccine-induced protection was correlated with an augmented local recall response in the gastric mucosa, with increased proportions of CD4(+) T cells, neutrophils and reduced proportions of CD4(+) Treg. CD4(+) T cells isolated from the stomachs of vaccinated mice proliferated ex vivo in response to H. pylori antigen, and secreted Th1 cytokines, particularly IFN-γ. This detailed analysis of local gastric immune responses provides insight into the mechanism of vaccine-induced protection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21038469     DOI: 10.1002/eji.200940219

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection.

Authors:  Louise Sjökvist Ottsjö; Carl-Fredrik Flach; John Clements; Jan Holmgren; Sukanya Raghavan
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

Review 2.  Gastric organoids: Advancing the study of H. pylori pathogenesis and inflammation.

Authors:  Sulaimon Idowu; Paul P Bertrand; Anna K Walduck
Journal:  Helicobacter       Date:  2022-04-05       Impact factor: 5.182

3.  Cytotoxin-Associated Gene A-Negative Helicobacter pylori Promotes Gastric Mucosal CX3CR1+CD4+ Effector Memory T Cell Recruitment in Mice.

Authors:  Heqiang Sun; Taojun He; Yanan Wu; Hanmei Yuan; Jie Ning; Zhenhua Zhang; Xinli Deng; Bin Li; Chao Wu
Journal:  Front Microbiol       Date:  2022-01-27       Impact factor: 5.640

4.  Leptin, CD4(+) T(reg) and the prospects for vaccination against H. pylori infection.

Authors:  Anna K Walduck; Dorit Becher
Journal:  Front Immunol       Date:  2012-10-15       Impact factor: 7.561

Review 5.  Isolation of lymphocytes from the human gastric mucosa.

Authors:  Masaya Iwamuro; Takahide Takahashi; Natsuki Watanabe; Hiroyuki Okada
Journal:  World J Methodol       Date:  2021-07-20

6.  Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization.

Authors:  Louise Sjökvist Ottsjö; Frida Jeverstam; Linda Yrlid; Alexander U Wenzel; Anna K Walduck; Sukanya Raghavan
Journal:  Immunology       Date:  2016-11-07       Impact factor: 7.397

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.